$AVAH

Aveanna Healthcare Holdings, Inc.

2
1
0

No SEC Form 4 filings for $AVAH in the last 30 days.

Low

Aveanna Healthcare Holdings, Inc. (AVAH): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Aveanna Healthcare Holdings, Inc. (AVAH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001832332 0001832332 2026-08-05 2026-08-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 05

Raymond James Names Top Healthcare Stocks for August

Raymond James updated its August healthcare top picks, adding Aveanna Healthcare (AVAH) ahead of its Aug. 13 earnings, and Carriage Services (CSV) after a ~20% decline since April, citing stabilizing funeral trends and valuation around 8x 2027 estimated EBITDA. It also added Viking Therapeutics (VKTX) for upcoming clinical readouts.

Markets: Three stocks analysts are chasing as the AI rally cools

The article says investors are rotating from highly valued AI infrastructure toward healthcare, citing a Bank of America survey and recent sector performance. It highlights three healthcare stocks: Aurinia Pharmaceuticals (AUPH) with Q1 revenue $77.7M and EPS $0.25; Fortrea (FTRE) raising full-year sales and adjusted EBITDA; and Aveanna (AVAH) after a $175.5M acquisition, guiding FY revenue $2.63B-$2.65B.

AVAH sentiment & insider activity

Over the past 7 days, alphai's AI scored 3 news stories mentioning AVAH (Aveanna Healthcare Holdings, Inc.). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.

Recent AVAH coverage spans insider activity, sector analysis and mergers & acquisitions.

What's driving AVAH

  • Board/committee leadership changes are typically low-to-moderate impact, but can affect governance optics and committee oversight continuity.

    SEC EDGAR 8-K · Aug 7, 2026

  • Analyst list addition is a sentiment catalyst tied to an upcoming earnings date, but it is not a fundamental disclosure.

    investing.com · Aug 6, 2026

  • AVAH’s acquisition and guidance raise are the most direct, tradable company-specific catalysts in the piece.

    businesspost.ie · Aug 1, 2026

  • Reported shortlist and bid deadline create near-term deal optionality and valuation framing for Avisena’s equity risk premium.

    businesstimes.com.sg · Jul 3, 2026

  • Reported process for selling ~20%-25% of Avisena could reprice deal expectations and near-term M&A optionality for the seller/target.

    dealstreetasia.com · Jul 2, 2026

alphai scores every news story that mentions AVAH with an AI model for sentiment and relevance, and aggregates insider trades from Aveanna Healthcare Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AVAH

Score

Aveanna Healthcare Holdings, Inc. (AVAH): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Aveanna Healthcare Holdings, Inc. (AVAH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001832332 0001832332 2026-08-05 2026-08-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 05

Raymond James Names Top Healthcare Stocks for August

Raymond James updated its August healthcare top picks, adding Aveanna Healthcare (AVAH) ahead of its Aug. 13 earnings, and Carriage Services (CSV) after a ~20% decline since April, citing stabilizing funeral trends and valuation around 8x 2027 estimated EBITDA. It also added Viking Therapeutics (VKTX) for upcoming clinical readouts.

Markets: Three stocks analysts are chasing as the AI rally cools

The article says investors are rotating from highly valued AI infrastructure toward healthcare, citing a Bank of America survey and recent sector performance. It highlights three healthcare stocks: Aurinia Pharmaceuticals (AUPH) with Q1 revenue $77.7M and EPS $0.25; Fortrea (FTRE) raising full-year sales and adjusted EBITDA; and Aveanna (AVAH) after a $175.5M acquisition, guiding FY revenue $2.63B-$2.65B.

Bain, KKR, KV Asia shortlisted for Malaysia’s Avisena Healthcare stake sale as valuation hits US$368 million: sources

Bain Capital, KKR and KV Asia have been shortlisted to buy a 20–25% minority stake in Malaysia’s Avisena Healthcare, valuing the company at about RM1.5 billion (US$368m), according to two sources. Binding bids are due by end-July. The stake is estimated at RM300–400m. KKR and Bain declined comment; Avisena and KV Asia did not respond.

Related tickers